What is the Fiscal Year for Zealand Pharma?
Date: November 14, 2026
Zealand Pharma's current fiscal year starts on February 1, 2026, and ends on January 31, 2027. Their current quarter is Q2, which ends on August 1, 2026.
Current Fiscal Year Overview
Fiscal Year Start
February 1, 2026
Fiscal Year End
January 31, 2027
Current Quarter
Q2
Current Quarter End
August 1, 2026
Quarterly Breakdown
Q1
Feb 1, 2026 – Apr 30, 2026
Q2
May 1, 2026 – Jul 31, 2026
Q3
Aug 1, 2026 – Oct 31, 2026
Q4
Nov 1, 2026 – Jan 31, 2027
Company Information
Headquarters
Denmark
Industry
Biotechnology Research
Stock Symbol
ZEAL
Website
https://zealandpharma.comDescription
At Zealand Pharma, we are a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals, bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. Ten drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market. Our current pipeline of internal product candidates focuses on obesity, chronic inflammation, and certain rare diseases. Our leading obesity programs are backed by strong partners, including Roche and Boehringer Ingelheim. We are based in Copenhagen (Søborg), Denmark, with a team in the U.S. For further information about our business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Zealand Pharma and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.